Activation of mitogen‐activated protein kinase by muscarinic receptors in astroglial cells: Role in DNA synthesis and effect of ethanol

Abstract

Mitogen-activated protein kinase (MAPK) can be phosphorylated by mitogens binding to G-protein-coupled receptors and is considered a major pathway involved in cell proliferation. In this study, we report on the activation of MAPK by muscarinic acetylcholine receptors in astroglial cells, namely the 1321N1 human astrocytoma cell line, primary rat cortical astrocytes, and fetal human astrocytes. Carbachol caused a rapid and transient phorphorylation of MAPK (ERK1/2) in all cell types, with an increase in MAPK activity, without changing the levels of MAPK proteins. Human astrocytoma cells were used to characterize the effect of carbachol on MAPK. Experiments with M 2 -and M 3 -receptor subtype-selective antagonists, and with pertussis toxin, indicated that the M 3 subtype is responsible for activating MAPK in glial cells. Pretreatment of cells with the protein kinase C (PKC) inhibitor bisindolylmaleimide I, or downregulation of PKC by 24-h treatment with the phorbol ester TPA inhibited carbachol-induced MAPK activation. Additional experiments with PKC ␣-or PKC ⑀-specific compounds indicated that the ⑀ isozyme of PKC is primarily involved in MAPK activation by carbachol. Chelation of calcium also inhibited MAPK activation by carbachol. Two MEK (MAPK kinase) inhibitors inhibited carbacholinduced DNA synthesis but only at concentrations that exceeded those sufficient to block carbachol-induced MAPK activation. Ethanol (Յ200 mM) had no effect on MAPK when present alone and did not affect carbachol-induced MAPK activation under various experimental conditions, although it inhibits carbachol-induced DNA synthesis at low concentrations (10-100 mM). These results suggest that activation of MAPK by carbachol may be necessary but not sufficient for its mitogenic effect in astroglial cells, and that does not represent a target for ethanol-induced inhibition of DNA synthesis elicited by muscarinic receptors. GLIA 35:111-120, 2001.

Differential effects of simvastatin and pravastatin on expression of Alzheimer's disease-related genes in human astrocytes and neuronal cells

“…Primary human astrocytes from four different donors (gift from Dr. Möller, Department of Neurology, University of Washington, Seattle) were prepared from tissue obtained from legally aborted fetuses (Birth Defects Laboratory, University of Washington, Seattle) using previously described methodology ( 19 ). Primary human astrocytes and SK-N-SH neuroblastoma cell line (ATCC) were plated on 6-well plates and grown in DMEM supplemented with 5% or 8% fetal calf serum (HyClone, Logan, UT), respectively, at 37°C, 5% CO 2 until 80% confl uent.…”

Widespread distribution of PLTP in human CNS: evidence for PLTP synthesis by glia and neurons, and increased levels in Alzheimer's disease

“…Cultures were prepared from brains of legally aborted human fetuses (12-15 weeks gestation) as previously described (27). Conditioned serum-free medium was collected after 48 h, briefly centrifuged, and immediately used for PLTP activity assay and Western blotting.…”

M3 Muscarinic Receptor Antagonists Inhibit Small Cell Lung Carcinoma Growth and Mitogen-Activated Protein Kinase Phosphorylation Induced by Acetylcholine Secretion

“…The M2 and M4 receptors are coupled to Gi and inhibit adenylyl cyclase formation (15). Muscarinic stimulation of cancer growth has been reported for colon (16), lung (14), glial (17), and prostate cancers (18), and in ovarian carcinomas, expression of muscarinic receptors correlates with a poor prognosis (19). In colon and prostate carcinomas, tumor growth has been associated with stimulation of M3 receptors (16,18).…”